T HE early years after menopause are characterized by an accelerated rate of bone turnover resulting in a significant loss of bone. Heaney and colleagues (1) have suggested that 15-20% of the skeleton may be lost by 10 years following menopause. However, treatments exist that have been shown to oppose this accelerated bone loss. It is clear that hormone replacement therapy (HRT) begun at menopause either reduces or abolishes the accelerated bone turnover in most women, maintaining bone density for up to a decade (2) . In addition, weight-bearing exercise begun after menopause has been shown to reduce bone loss or even increase bone mass in estrogen-deficient women (3, 4) . It has also been suggested that estrogen and weight-bearing exercise begun postmenopause have an additive effect in increasing bone mass (5) . Thus, it appears that weight-bearing exercise begun following menopause is beneficial to the skeleton either alone or in conjunction with HRT.
However, it is presently unclear how chronic weight-bearing exercise (specifically running) begun prior to menopause affects bone mineral density (BMD), as studies utilizing this population group have been equivocal. Lane' and coworkers (6) demonstrated 40% greater bone mineral in the lumbar vertebrae of chronic runners compared to controls. However, these results were based on only six subjects per group. In contrast, Kirk and associates (7) found no difference in bone mass between runners and closely matched controls, whereas Nelson and coworkers (8) found that bone mass was lower in runners compared to slightly heavier sedentary subjects. The latter results suggest that chronic endurance exercise might not be beneficial to bone, and there is evidence that this type of exercise can create an environment that could be harmful to the skeleton (9) . Unfortunately, comparisons of chronic exercisers and sedentary subjects can be confounded by body weight, body composition, and hormonal differences related to activity. We have proposed a model that would be useful in determining the effects of chronic running on bone following menopause, utilizing a cross-sectional comparison of premenopausal and postmenopausal master athletes. Use of this sample group reduces the confound of differences in body weight and hormonal status related to chronic endurance training, as all have similar body mass and training background. Utilizing this model, we hypothesized that postmenopausal women runners on HRT would maintain bone mass at levels similar to those in the premenopausal group, but that postmenopausal women runners not on HRT would have significantly lower BMD than either estrogen-replete group. Further, we hypothesized that the rate of bone loss in the postmenopausal, nonestrogen-treated runners-predicted by the expected differences in bone mass between pre-and postmenopausal groups-would differ from those expected in untreated sedentary women, suggesting a protective effect of running exercise despite the absence of estrogen.
Therefore, the purpose of this study was to determine the effect of chronic running exercise alone, and in conjunction with HRT, on BMD in postmenopausal women.
METHODS
Subjects.-Forty-three women [15 premenopausal Hydrostatic weighing.-Body composition was estimated by hydrodensitometry. Residual lung volume was determined by the oxygen dilution method of Wilmore at the time ofunderwater weighing. Underwater weight was measured with a minimum of 3 trials, and the highest value attained was used in the calculations. Body fat was calculated from total body density using the equation of Siri.
Institutional Review Board of the University of Southern California. Subjects were free from diseases known to affect bone, and were similar in caloric and calcium consumption as determined by 3-day dietary records. The Post and PostE women were at least one year postmenopausal, as evidenced by the absence of menstruation in the previous 12 months. All participants were chronically active endurance athletes, running a minimum of 5 years and an average of 24 miles per week, and competing in races at least once per year. General characteristics of the subject groups are given in Table 1 .
Statistics.-Data were analyzed using the Statistical Package for Social Sciences (SPSS) software, version 8.0. Comparisons among the three groups were done by analysis of covariance (ANCOVA), with body weight as the covariate. Follow-up tests were conducted to evaluate pairwise differences among the adjusted means, with Holm's sequential Bonferroni procedure used to control for Type I error. Independent sample t tests were used to compare the Post and PostE groups on variables unique to those two groups. Pearson correlations were utilized to examine relationships between variables for all groups combined.
Significance was predetermined at p < .05.
vided by the software manufacturer. These scores are ± standard deviations from predicted values,representing a value of zero.
Training history.-Subjects' training history was selfreported by questionnaire. Subjects were asked for years of training, miles run per week, training pace': personal best and most recent times for competitions, and a sample training week. Reported values were confirmed by oral interview.
Menstrual history.-Subjects completed a menstrual history questionnaire, including age at menarche, current menstrual history, age at menopause (if relevant), and current and past oral contraceptive (OC) and HRT use. Reported values were confirmed by oral interview.
RESULTS
General characteristics of subjects are shown in Table 1 .Age did not differ between Post and PostE, whereas Pre was significantly younger than both postmenopausal groups (F = 11.27;p < .05). The groups did not differ in body weight, although Pre was significantly taller (F = 3.13; p < .05), had significantly lower body fat (F = 3.55, p < .05), and significantly greater total lean mass (F =8.29,p < .05) than Post. Although body weight did not differ statistically, we utilized ANCOVA to control for body weight in comparing the three groups, due to the slightly higher body weight in the Pre group, and the finding of significantcorrelations between bone mass and body weight (described below). Yearsof training,miles run per week, and maximal aerobic capacity were not differentfor the three groups, as shown in Table 2 .
Menstrual history data are shown in Table 3 . The groups were not different for age at menarche. Ten Pre, 8 PostE, and 6 Post subjects reported previous OC use; years of OC use and years since OC use were not different between the three groups. Years
Muscle strength.-Isokinetic knee extension strength and isometric knee extension strength of the right knee were assessed using a KinCom dynamometer (Chattecx Corp., Hixson, TN). Strength testing was preceded by the V0 2max test in all cases, serving as the warmup. Following adequate recovery, subjects received instruction, including practice efforts, on the test procedures. Three maximal repetitions of each exercise were performed, with l-minute recovery between repetitions. Isokinetic extension strength was measured concentrically at 60°'s-1 between 15-80°of knee flexion (0°= full extension). Strength is reported as the peak torque achieved in Newton-meters (N ·m). Isometric extension strength was measured at 60, 45, and 30°(0°= full extension). The peak torque (in N -rn) achieved among the three angles is reported. 
Maximal aerobiccapacity.-A modified Balke protocol was performed on a treadmill to determine each subject's maximal aerobic capacity (V0 2max). After an initial 2 minutes at 2.5 mph and 0% grade, speed and grade were increased by 0.5 mph and 2% at 2-minute stages until the subjects reached volitional fatigue. Volume of expired ventilation was determined by a pneumotach, and expired volume of oxygen (V0 2 ) and carbon dioxide (VC0 2 ) was measured via open-circuit indirect calorimetry using a Parvomedics system (Consentius Technologies, Sandy, Utah). The analyzers were calibrated prior to testing for volume and concentration with known gases. Twelve-lead EKG (Quinton Q750B, Bothell, WA) was monitored throughout exercise, and a board-certified physician of internal medicine was present during the testing.
Bone densitometry.-The BMD of the lumbar spine (L]-L 4 )
(SBD) and nondominant proximal femur (H BD), and BMD and bone mineral content (BMC) of the total body (TBD and TBd were measured by dual energy x-ray absorptiometry (DEXA) using a Hologic QDR-1500 system, software version 7.10 (Hologic, Waltham, MA). Quality control was ensured daily by use of a phantom, and the measurements were maintained within the manufacturer's precision standards of~1.0% for the spine and 1.5% for the total hip. Reproducibility, assessed in 10 healthy volunteers,ranged from 0.8-2.0%. Subjects' t scores (comparison to predicted peak bone mass) and z scores (comparison to agepredicted bone mass) were obtained using normative values pro- 
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past menopause did not differ between Post and PastE. However, statistical power for this co mparis on was inadequ ate given the wide variance and small number of subjec ts. For Po stE , years past menopause and years on HRT were not significantly different, and only two of the PastE group did not begin HRT immediately at menopause. Two forms of estrogen replacement were used by the subjects in the PostE group. Twelve women took co nj ugated estro gen , 10 at a do sage of 0.62 5 mg and 2 at a dosage of 0 .3 mg. Th e rem ain ing 3 wome n in the Pa stE gro up used estradiol at a dosage of 0.05 mg. The HRT utilized by 7 of the PostE group included dosages of progesterone (2.5-5.0 mg).
Data on BMD and BMC are presented in Table 4 and Figure  I . The hip measure reported is the Hol ogic total hip value. Pre and Po stE did not di ffer sig ni ficantly for T BD' TBC' and SBD' In comparison to age-predicted norm s (2 scores), Pre was 0.5 to 0.75 standard deviations greater than predicted forT BD, HBD> and SSD' Th e BMD va lues fo r PostE ran ged from 0 .1 to 0 .5 standard deviations greater than age-predicted , whereas for Post the ran ge was from -0.2 to -0 .5 standard de viations less than age-predicted . None of these values differed signi ficantly from the popul ation norms as determined by one-sample t tests.
Strength data are presented in Table 2 and Figure 2 . Isokinetic knee exten sion streng th was significantly gre ater in Pre co mpared to Post, a difference of 23%. Althou gh not reachin g statistical significance, Pre also had 16% greater mean isometric knee exten sion strength than Post. In contrast, Pre did not differ from PastE in muscle strength, nor did PastE differ from Post Pearson co rre latio ns revealed signi fica nt inver se relationships with age for HBMD (r = -0.30 , P < .05 ), iso metric knee extension strength (r = -0.32, P < .05), total lean mass (r = -.34, P < .05) and maximal aero bic capaci ty (Absolute: r =-0.49, P < .05; Rel ative: r = -0.38, P < .05). Th e relat ion ships between age and BMD are plotted in Figure 3 . Ag e was not related to body weight, and none of the BMD values were related to muscle strength, aerobic fitne ss, or training history. However, H sn and Tso were significantly related to body weight and total lean mass. The se relationships are plotted in Figure 4 . cisersexperience any skeletal gainsduringtheearlyyearsof training, after whichbonemass would be expectedto plateauwithno further increase from thechronic exercise. Thus, although thecombination of running and HRT might not be expectedto increase BMD in this group of women,it would be expectedto maintain bone mass at nearlypremenopausal levels. The fact that that our datasuggest a lossofbonemassdespite HRTis as yetunexplained.
It remains possiblethat the dosage of estrogenutilizedby the subjects in our study was insufficient to protect bone, Lindsay (15) has stated that not all patients treated with the minimum dose of estrogenconservebone. Whetherthis is due to estrogen resistance, interference from other factors, or lack of compliance with treatment has not beenreported. Certainly, delayedonset of HRT following menopause, and/or poor compliance with the medication, couldprovide an explanation forour findings if these data were incorrectly reportedby our subjects. Additionally, the postmenopausal athletesmay have had a lowerpeak: bone mass, or they may have experiencedgreater premenopausal bone loss due to premenopausal bouts of amenorrhea. However, only one athlete in the postmenopausal group reported an amenorrheic eventduring her lifetime. Thus, it is difficult at best to determine precisely the influence of thesefactors on our results.
Finally, it is possible thatsomeaspectcreated by thechronic nature of the exercise undertaken by thesesubjects created anenviron- tionregarding the interaction betweenchronicrunningand bone. Both body mass (10, 11) and aerobic capacity (12) have been shownto predictbone mass in olderwomen. Giventhesimilarity betweenour groups in these variables, and the chronicnatureof thetraining undertaken by oursubjects, we wereabletocontrol for theinfluence of bodyweight andtraining history on thedeterminationof howchronic running affects BMDaftermenopause.
The key finding of this study was that chronic running in the presence of HRT appeared unable to maintain BMD of the hip in postmenopausal women.These data indicate that the levelof physicalactivityundertakenby these subjects, even in the presence of HRT, is not an adequate stimulus to maintain hip bone mass. In contrast, HRT and exercisemaintainedTBD and TBe at levels similarto those of premenopausal women runners.
The finding of differences in BMDbetween Pre and PostEwas unexpected Theliterature is clearthatestrogen replacement canalmostcompletely abolishbonelossassociated with menopause in most women. The work of Lindsay and colleagues (2) demonstratedlong-termconservation of bone with estrogen treatment, begunat the onset of menopause, that lasted at least up untilthe age of 70 years.The estrogen-treated womenin our studybegan treatment at menopause, yet theyhadsignificantly lowerBMDof the hip, and a trend toward lower BMD of the spine, than premenopausal women of similar weight and training history. The reasons forthesedifferences areunclear, as the interaction between chronicexerciseand HRT has not been well studied. Some data suggest that weight-bearing exercise enhances the effectof estrogento increase bonemass(5),buttheseresults wereestablished in women who began HRT and exerciseseveralyears after menopause. It has been suggested thattheremightbe more potential to add bone mass once postmenopausalloss has already occurred (13) ,making it likelythat the additive effectof estrogenand exercisewasin partdue to a moreresponsive skeleton. In contrast, our subjects had been chronically training from several yearspriorto menopause, suggesting they may be acclimated to the exercise stimulus. Moreover, Mosekilde (14) suggested that chronicexer-
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M455 ment detrimental to bone evenin the presenceof HRT. Risk factors for osteoporosis that are known to be prominentin female athletes includelowbodyweight, low body fat,highcortisol levels, and low estrogen levels (9) .As well, Nelsonandcoworkers (8)demonstrated lowerserumestrogen in non-HRTtreated, chronically trainedpostmenopausal womenrunnerswhen comparedto sedentary controls, likelydue to lowerbodyfatpercentage. An adverse effect of chronic running on bone mass in men has also been suggested (16) ; this was attributed to hormonal changesassociated withendurance training,and certainly warrants furtherinvestigation.
The secondmajor findingof this study was that exercisealone was not able to reduce the expected rate of bone loss in postmenopausal women. The Post group had 17% lower BMD of the hip and the lumbar spine when compared to Pre, similar to the predicted 15-20% loss in bone mass during the first 10 years followingmenopause (1) . TBD was also significantly lower in the Post group, although the difference amounted to only 11%. The finding of a slower rate of loss in TBD than H BD and SBD is not surprising. Cortical bone, which is primarily reflected by TBD, is affected more slowly by menopause than trabecular bone, of which HBD and SBD are more reflective (17) .
We did notexpectthatexercisealonewouldbe a sufficient stimulus to completelymaintain bone mass in the absenceof estrogen. There is no evidence to date in humans that suggests otherwise. However, in young women who are amenorrheic, studies have shown a skeletal benefit to running exercise in comparison with sedentary subjects (18) . Thus, it could be expected that exercise would slow the rate of bone loss in postmenopausal women not utilizingHRT. Our data, althoughnot conclusivedue to the crosssectional nature of the comparison, suggests that it does not in chronic exercisers. This supports the work of Kirk and associates (7), who found no differencein bone mass between chronic runners and closely matched sedentary controls.These findingscall intoquestionthe benefitof chronicrunningexercise to the skeleton in postmenopausal women,and warrantfurtherinvestigation.
In conclusion, the results of this study suggest that HRT and chronic running exercise are unable to maintain hip bone mass in postmenopausal women, wheteas total body bone mass is maintained at nearly premenopausal levels. Moreover, the results suggest that chronic running alone is unable to prevent or reduce the bone loss associated with menopause.
